| 1st Jun 2026 3:05 pm |
RNS |
Admission of Further Securities to Trading |
| 1st Jun 2026 3:00 pm |
RNS |
Total Voting Rights |
| 29th May 2026 7:00 am |
RNS |
Imfinzi approved in US for early bladder cancer |
| 27th May 2026 7:00 am |
RNS |
US FDA decision date on camizestrant extended |
| 26th May 2026 7:00 am |
RNS |
Enhertu recommended in EU for HER2+ solid tumours |
| 26th May 2026 7:00 am |
RNS |
Camizestrant recommended for breast cancer in EU |
| 26th May 2026 7:00 am |
RNS |
Datroway approved in US for 1L triple-negative BC |
| 18th May 2026 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 18th May 2026 7:05 am |
RNS |
Enhertu approved in two HER2+ early BC settings |
| 18th May 2026 7:00 am |
RNS |
Baxfendy approved in the US for hypertension |
| 14th May 2026 7:00 am |
RNS |
Imfinzi + EV improves EFS & OS in bladder cancer |
| 1st May 2026 3:00 pm |
RNS |
Total Voting Rights and Admission of Shares |
| 1st May 2026 7:05 am |
RNS |
FDA ODAC vote on camizestrant in breast cancer |
| 1st May 2026 7:00 am |
RNS |
FDA ODAC recommends Truqap in prostate cancer |
| 29th Apr 2026 7:00 am |
RNS |
1st Quarter Results |
| 28th Apr 2026 7:00 am |
RNS |
Breztri approved in the US for asthma |
| 27th Apr 2026 7:00 am |
RNS |
Saphnelo self-administration approved in the US |
| 23rd Apr 2026 7:00 am |
RNS |
Directorate change |
| 21st Apr 2026 7:00 am |
RNS |
I CAN PhIII interim analysis met primary endpoint |
| 20th Apr 2026 7:00 am |
RNS |
Third tozorakimab positive Phase III in COPD |
| 9th Apr 2026 5:15 pm |
RNS |
Result of AGM |
| 2nd Apr 2026 7:00 am |
RNS |
Imfinzi+Imjudo improves PFS in early liver cancer |
| 1st Apr 2026 3:00 pm |
RNS |
Total Voting Rights and Admission of Shares |
| 31st Mar 2026 7:00 am |
RNS |
Efzimfotase alfa Ph3 program show positive results |
| 27th Mar 2026 7:00 am |
RNS |
Tozorakimab met OBERON/TITANIA primary endpoints |
| 20th Mar 2026 11:00 am |
RNS |
Notification of Admission of Shares |
| 16th Mar 2026 7:00 am |
RNS |
Imfinzi approved in EU for early gastric cancer |
| 16th Mar 2026 7:00 am |
RNS |
Imfinzi approved in EU for early gastric cancer |
| 10th Mar 2026 11:00 am |
RNS |
Notice of AGM |
| 10th Mar 2026 11:00 am |
RNS |
Notice of AGM |
| 6th Mar 2026 11:10 am |
RNS |
Director/PDMR Shareholding |
| 6th Mar 2026 11:05 am |
RNS |
Director/PDMR Shareholding |
| 6th Mar 2026 11:00 am |
RNS |
Director/PDMR Shareholding |
| 2nd Mar 2026 3:00 pm |
RNS |
Total Voting Rights |
| 26th Feb 2026 7:00 am |
RNS |
AstraZeneca prices a $2bn bond offering |
| 25th Feb 2026 7:00 am |
RNS |
Filing of Form 20-F with SEC |
| 24th Feb 2026 11:00 am |
RNS |
Annual Financial Report |
| 24th Feb 2026 7:00 am |
RNS |
Directorate change |
| 20th Feb 2026 7:00 am |
RNS |
Fixed-duration Calquence combo approved in US |
| 10th Feb 2026 7:00 am |
RNS |
Final Results |
